Meihua International Medical Technologies Co., Ltd. (MHUA) Financial Ratios
7 years of historical data (2018–2024) · Healthcare · Medical - Instruments & Supplies
EV/EBITDA
↓
-0.40
↓-107% vs avg
5yr avg: 5.70
30Y Low0.1·High15.3
P/FCF
0.14
↓-78% vs avg
5yr avg: 0.65
30Y Low0.7·High0.7
P/B Ratio
↓
0.01
↓-98% vs avg
5yr avg: 0.57
30Y Low0.1·High1.4
ROE
↓
7.1%
↑-48% vs avg
5yr avg: 13.7%
30Y Low5%·High35%
Debt/EBITDA
↑
0.53
↑+37% vs avg
5yr avg: 0.39
30Y Low0.1·High0.6
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MHUA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Meihua International Medical Technologies Co., Ltd. trades at 0.2x earnings, 98% below its 5-year average of 11.5x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 99%. On a free-cash-flow basis, the stock trades at 0.1x P/FCF, 78% below the 5-year average of 0.7x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $2M | $9M | $35M | $194M | — | — | — | — |
| Enterprise Value | $-5931105 | $1M | $26M | $174M | — | — | — | — |
| P/E Ratio → | 0.19 | 0.86 | 3.02 | 30.67 | — | — | — | — |
| P/S Ratio | 0.02 | 0.10 | 0.36 | 1.88 | — | — | — | — |
| P/B Ratio | 0.01 | 0.06 | 0.24 | 1.40 | — | — | — | — |
| P/FCF | 0.14 | 0.65 | — | — | — | — | — | — |
| P/OCF | 0.14 | 0.65 | 15.57 | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
MHUA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.01 | 0.27 | 1.68 | — | — | — | — |
| EV / EBITDA | -0.40 | 0.10 | 1.71 | 15.30 | — | — | — | — |
| EV / EBIT | -0.41 | 0.09 | 1.69 | 15.69 | — | — | — | — |
| EV / FCF | — | 0.10 | — | — | — | — | — | — |
MHUA Profitability
Margins and return-on-capital ratios measuring operating efficiency
Meihua International Medical Technologies Co., Ltd. earns an operating margin of 14.8%. Operating margins have expanded from 10.5% to 14.8% over the past 3 years, signaling improving operational efficiency. ROE of 7.1% is modest. ROIC of 7.4% represents adequate returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 34.4% | 34.4% | 34.1% | 36.9% | 38.3% | 41.7% | 40.5% | 42.1% |
| Operating Margin | 14.8% | 14.8% | 15.1% | 10.5% | 25.2% | 26.3% | 24.3% | 25.3% |
| Net Profit Margin | 11.2% | 11.2% | 12.0% | 6.0% | 20.1% | 21.4% | 19.4% | 20.4% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | 7.1% | 7.1% | 8.1% | 5.1% | 21.9% | 26.4% | 29.6% | 34.8% |
| ROA | 6.1% | 6.1% | 6.9% | 4.2% | 17.2% | 21.2% | 22.8% | 24.8% |
| ROIC | 7.4% | 7.4% | 8.6% | 7.3% | 21.3% | 27.7% | 37.3% | 45.4% |
| ROCE | 9.4% | 9.4% | 10.3% | 8.7% | 27.3% | 32.5% | 37.2% | 43.1% |
MHUA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Meihua International Medical Technologies Co., Ltd. carries a Debt/EBITDA ratio of 0.5x, which is very conservative (84% below the sector average of 3.3x). The company holds a net cash position — cash of $16M exceeds total debt of $8M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns. Interest coverage of 9.5x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 |
| Debt / EBITDA | 0.53 | 0.53 | 0.48 | 0.60 | 0.19 | 0.13 | 0.13 | 0.10 |
| Net Debt / Equity | — | -0.05 | -0.07 | -0.14 | -0.03 | -0.05 | -0.23 | -0.29 |
| Net Debt / EBITDA | -0.54 | -0.54 | -0.63 | -1.75 | -0.11 | -0.17 | -0.68 | -0.65 |
| Debt / FCF | — | -0.55 | — | — | — | — | -37.76 | -1.08 |
| Interest Coverage | 9.50 | 9.50 | 58.52 | 55.49 | 145.29 | 171.09 | 198.26 | — |
Net cash position: cash ($16M) exceeds total debt ($8M)
MHUA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Meihua International Medical Technologies Co., Ltd.'s current ratio of 5.26x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 5.60x to 5.26x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.26 | 5.26 | 5.27 | 5.60 | 3.34 | 3.17 | 3.88 | 2.78 |
| Quick Ratio | 5.21 | 5.21 | 5.21 | 5.55 | 3.30 | 3.11 | 3.81 | 2.68 |
| Cash Ratio | 0.59 | 0.59 | 0.68 | 1.11 | 0.28 | 0.34 | 1.18 | 0.82 |
| Asset Turnover | — | 0.52 | 0.56 | 0.63 | 0.76 | 0.84 | 1.09 | 1.21 |
| Inventory Turnover | 45.12 | 45.12 | 39.58 | 58.15 | 51.33 | 39.14 | 46.26 | 23.76 |
| Days Sales Outstanding | — | 433.13 | 373.95 | 321.51 | 303.41 | 239.98 | 162.33 | 159.00 |
MHUA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Meihua International Medical Technologies Co., Ltd. returns 9.6% to shareholders annually primarily through share buybacks. The earnings yield of 100.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 100.0% | 115.9% | 33.1% | 3.3% | — | — | — | — |
| FCF Yield | 100.0% | 153.5% | — | — | — | — | — | — |
| Buyback Yield | 9.6% | 2.1% | 0.0% | 0.0% | — | — | — | — |
| Total Shareholder Yield | 9.6% | 2.1% | 0.0% | 0.0% | — | — | — | — |
| Shares Outstanding | — | $273717 | $239400 | $234111 | $236000 | $241400 | $241400 | $200000 |
Peer Comparison
Compare MHUA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MHUAYou | $2M | 0.2 | -0.4 | 0.1 | 34.4% | 14.8% | 7.1% | 7.4% | 0.5 |
 CODA | $134M | 32.2 | 17.9 | 22.2 | 66.5% | 17.1% | 7.4% | 11.2% | 0.1 |
 ATEC | $1B | -8.1 | 3752.1 | 422.6 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 XTLB | $293767 | -0.3 | — | — | 0.7% | -481.6% | -26.8% | -54.1% | — |
 MMSI | $4B | 29.3 | 13.1 | 17.2 | 48.7% | 12.2% | 8.7% | 7.2% | 2.8 |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 ANGO | $469M | -13.6 | — | — | 53.9% | -13.7% | -17.5% | -22.9% | — |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
See MHUA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MHUA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MHUA vs CODA
Side-by-side business, growth, and profitability comparison vs Coda Octopus Group, Inc..
Start ComparisonMHUA — Frequently Asked Questions
Quick answers to the most common questions about buying MHUA stock.
What is Meihua International Medical Technologies Co., Ltd.'s P/E ratio?
Meihua International Medical Technologies Co., Ltd.'s current P/E ratio is 0.2x. The historical average is 11.5x.
What is Meihua International Medical Technologies Co., Ltd.'s EV/EBITDA?
Meihua International Medical Technologies Co., Ltd.'s current EV/EBITDA is -0.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 5.7x.
What is Meihua International Medical Technologies Co., Ltd.'s ROE?
Meihua International Medical Technologies Co., Ltd.'s return on equity (ROE) is 7.1%. The historical average is 19.0%.
Is MHUA stock overvalued?
Based on historical data, Meihua International Medical Technologies Co., Ltd. is trading at a P/E of 0.2x. Compare with industry peers and growth rates for a complete picture.
What are Meihua International Medical Technologies Co., Ltd.'s profit margins?
Meihua International Medical Technologies Co., Ltd. has 34.4% gross margin and 14.8% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does Meihua International Medical Technologies Co., Ltd. have?
Meihua International Medical Technologies Co., Ltd.'s Debt/EBITDA ratio is 0.5x, indicating low leverage. A ratio below 2x is generally considered financially healthy.